Abstract:Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic disease and frequent indication for liver transplantation worldwide. With harmful alcohol use as the primary risk factor, increasing alcohol use over the past decade has resulted in rapid growth of the ALD-related healthcare burden. The spectrum of ALD ranges from early asymptomatic liver injury to advanced disease with decompensation and portal hypertension. Compared with those with other etiologies of liver disease, patients with ALD progress faster and more often present at an advanced stage. A unique phenotype of advanced disease is alcohol-associated hepatitis (AH) presenting with rapid onset or worsening of jaundice, and acute on chronic liver failure in severe forms conveying a 1-month mortality risk of 20%–50%. The model for end stage disease score is the most accurate score to stratify AH severity (>20 defined as severe disease). Corticosteroids are currently the only available therapeutic with proven efficacy for patients with severe AH, providing survival benefit at 1 month in 50%–60% of patients. Abstinence of alcohol use, a crucial determinant of long-term outcomes, is challenging to achieve in ALD patients with concurrent alcohol use disorder (AUD). As patients with ALD are rarely treated for AUD, strategies are needed to overcome barriers to AUD treatment in patients with ALD and to promote a multidisciplinary integrated care model with hepatology, addiction medicine providers, and social workers to comprehensively manage the dual pathologies of liver disease and of AUD. Liver transplantation, a definitive treatment option in patients with advanced cirrhosis, should be considered in selected patients with AH, who are unresponsive to medical therapy and have a low risk of relapse to posttransplant alcohol use. Level of evidence and strength of recommendations were evaluated using the Grading of Recommendations, Assessment, Development, and Evaluations system. This guideline was developed under the American College of Gastroenterology Practice Parameters Committee.

S4610 Unorthodox Alcoholic Liver Injury

Alcoholic Hepatitis: A Review

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

ACG Clinical Guideline: Alcohol-Associated Liver Disease

S4658 Perplexing "Pseudotumoral" Findings in Acute Alcohol-Associated Hepatitis

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Alcohol-associated liver disease - a current overview

Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity

Atypical Presentation of Alcoholic Liver Disease as Isolated Direct Hyperbilirubinaemia with Non Resolving Pneumonia Secondary to Multidrug Resistant Escherichia coli and Aspergillus Co-infection: A Case Report

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

S4477 A Case of Auto Brewery Syndrome (ABS) Complicating Cirrhosis and Leading to Liver Transplant

Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy

Alcohol or Gut Microbiota: Who Is the Guilty?

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

Alcohol and Hepatocellular Carcinoma

Streptococcus, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease

A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis

Novel potential biomarkers for severe alcoholic liver disease

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Atypical Presentation of Hepatocellular Carcinoma in a Chronic Alcoholic: Diagnostic Challenges and Therapeutic Approach

Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease